Brendan P. Rae
Corporate Officer/Principal bei New York Medical College
Profil
Brendan P.
Rae is an Adjunct Assistant Professor at New York Medical College since 1989.
He was previously an Executive Director at NPS Pharmaceuticals, Inc. from 2014 to 2015, a Senior Director-Licensing & Business Development at Purdue Pharma LP from 2003 to 2005, a Vice President-Business Development at VIA Pharmaceuticals, Inc. from 2005 to 2007, a Senior Vice President-Business Development at VIA Pharmaceuticals, Inc. from 2005 to 2010, a Chief Business Officer at Vivaldi Biosciences, Inc. from 2010 to 2011, a Chief Business Officer at Serina Therapeutics, Inc., and a Senior Vice President-Business Development at CytoDyn, Inc. He obtained his undergraduate and doctorate degrees from the University of Glasgow and his graduate degree from Seton Hall University School of Law.
Currently, Dr. Rae is an Adjunct Assistant Professor at New York Medical College.
Aktive Positionen von Brendan P. Rae
| Unternehmen | Position | Beginn |
|---|---|---|
| New York Medical College | Corporate Officer/Principal | 01.01.1989 |
Ehemalige bekannte Positionen von Brendan P. Rae
| Unternehmen | Position | Ende |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2015 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Corporate Officer/Principal | 01.11.2011 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2010 |
VIA Pharmaceuticals, Inc. /Old/
 VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology VIA Pharmaceuticals, Inc. develops pharmaceutical products. It focuses on small-molecule drugs that target inflammation in the blood vessel wall as an innovative approach to treatment of cardiovascular disease. The company's strategy is to identify, acquire and develop compounds that intervene in the process of vascular inflammation, to reduce the incidence of major cardiovascular events and provide a significant clinical benefit to patients. It was founded in June, 2004 by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given. VIA is headquartered in San Francisco, CA. | Corporate Officer/Principal | 07.06.2007 |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Brendan P. Rae
| University of Glasgow | Doctorate Degree |
| Seton Hall University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VIA PHARMACEUTICALS, INC. | Health Technology |
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| CYTODYN INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
VIA Pharmaceuticals, Inc. /Old/
VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology VIA Pharmaceuticals, Inc. develops pharmaceutical products. It focuses on small-molecule drugs that target inflammation in the blood vessel wall as an innovative approach to treatment of cardiovascular disease. The company's strategy is to identify, acquire and develop compounds that intervene in the process of vascular inflammation, to reduce the incidence of major cardiovascular events and provide a significant clinical benefit to patients. It was founded in June, 2004 by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given. VIA is headquartered in San Francisco, CA. | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
Serina Therapeutics, Inc.
 Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Commercial Services |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Retail Trade |
